A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated diseaseNour Sabiha Naji, Theodoros Karantanos, Ivana Gojo et al.|Blood Advances|2026Cited by 0